azathioprine has been researched along with Dermatitis Exfoliativa in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oksenov, BS | 1 |
Milevskaia, SG | 1 |
Petukhova, NL | 1 |
Levitskaia, NS | 1 |
Sergeev, SIa | 1 |
Lapière, CM | 1 |
Salmon, J | 1 |
2 other studies available for azathioprine and Dermatitis Exfoliativa
Article | Year |
---|---|
[Azathioprine treatment of psoriasis].
Topics: Adolescent; Adult; Azathioprine; Dermatitis, Exfoliative; Drug Evaluation; Female; Humans; Male; Mid | 1979 |
[An unusual indication for treatment with immunosuppressive agents: erythrodermic eczema].
Topics: Azathioprine; Dermatitis, Exfoliative; Eczema; Glucocorticoids; Humans; Male; Mercaptopurine; Middle | 1970 |